clinical trial · NCT07662057
A Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy Participants
Healthy VolunteersAB102Placebo
brief summary
The purpose of this study is assess the safety and tolerability of AB102 and characterize the pharmacokinetics (PK) profile of AB102 after single and multiple ascending oral dose(s).
started
Jul 9, 2026
primary completion
Dec 1, 2026
completion
Dec 1, 2026
last updated
Aug 25, 2026
official title
A Double-Blind, Randomized, Placebo-Controlled, Combined Single Ascending Dose and Multiple Ascending Dose First-In-Human Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AB102 in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol